Evidence map›Paper›PMID 30788502›Full record

ArticleThe Journal of infectious diseases2019

Evidence of Recent Genomic Evolution in Gonococcal Strains With Decreased Susceptibility to Cephalosporins or Azithromycin in the United States, 2014-2016.

Jesse C Thomas, Sandra Seby, A Jeanine Abrams, Jack Cartee, Sean Lucking, Eshaw Vidyaprakash, Matthew Schmerer, Cau D Pham, Jaeyoung Hong, Elizabeth Torrone and 6 more

Abstract read
In one paragraph

Article in The Journal of infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Analysis of minimum inhibitory concentrations of azithromycin, ceftriaxone and ciprofloxacin forEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026
    Article
  2. Establishing aMicrobiology spectrum · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Local emergence and global evolution ofAntimicrobial agents and chemotherapy · 2024
    Article
  7. Emergence ofAntibiotics (Basel, Switzerland) · 2024
    Article
  8. Emergence and evolution of mosaicFrontiers in microbiology · 2024
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. The Distribution and Spread of Susceptible and Resistant Neisseria gonorrhoeae Across Demographic Groups in a Major Metropolitan Center.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  17. Sustained Transmission of Neisseria gonorrhoeae with High-Level Resistance to Azithromycin, in Indianapolis, Indiana, 2017-2018.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Jesse C ThomasDivision of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
Sandra SebyDivision of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
A Jeanine AbramsDivision of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
Jack CarteeDivision of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
Sean LuckingDivision of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
Eshaw VidyaprakashDivision of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
Matthew SchmererDivision of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
Cau D PhamDivision of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
Jaeyoung HongDivision of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
Elizabeth TorroneDivision of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
Sancta St CyrDivision of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
William M ShaferDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia.
Kyle BernsteinDivision of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
Ellen N KershDivision of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
Kim M GernertDivision of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
Antimicrobial-Resistant Neisseria gonorrhoeae Working Group

Funding

Gonococci: Genetics of Resistance to PMN ProteinsR37AI021150 · NIAID · EMORY UNIVERSITY · PI SHAFER, WILLIAM MAURICE · 2010 to 2019
$3.9M
NIAID NIH HHS R37 AI021150
6 · The paper itself

Abstract

backgroundGiven the lack of new antimicrobials or a vaccine, understanding the evolutionary dynamics of Neisseria gonorrhoeae is a significant public and global health priority. We investigated the emergence and spread of gonococcal strains with decreased susceptibility to cephalosporins and azithromycin using detailed genomic analyses of gonococcal isolates collected in the United States, 2014-2016.

methodsWe sequenced genomes of 649 isolates collected through the Gonococcal Isolate Surveillance Project. We examined the genetic relatedness of isolates and assessed associations between clades and various genotypic and phenotypic combinations.

resultsWe identified a large and clonal lineage of strains (MLST ST9363) associated with elevated azithromycin minimum inhibitory concentration (AZIem), characterized by a mosaic mtr locus (C substitution in the mtrR promoter, mosaic mtrR and mtrD). Mutations in 23S rRNA were sporadically distributed among AZIem strains. Another clonal group (MLST ST1901) possessed 7 unique PBP2 patterns, and it shared common mutations in other genes associated with cephalosporin resistance.

conclusionsWhole-genome sequencing methods can enhance monitoring of antimicrobial resistant gonococcal strains by identifying gonococcal populations containing mutations of concern. These methods could inform the development of point-of-care diagnostic tests designed to determine the specific antibiotic susceptibility profile of a gonococcal infection in a patient.

Indexed as

Anti-Bacterial AgentsAzithromycinBacterial ProteinsCephalosporinsDrug Resistance, BacterialEvolution, MolecularGenomicsGenotypeGonorrheaHumansMaleMicrobial Sensitivity TestsMutationNeisseria gonorrhoeaePhenotypePromoter Regions, GeneticAnti-Bacterial AgentsAzithromycinBacterial ProteinsCephalosporinsRNA, Ribosomal, 23Santibiotic resistancecephalosporinsgenomic epidemiologygonorrheamacrolideNeisseria gonorrhoeae

Identifiers

PMID30788502
PMCPMC6581898

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.